First AD

Second AD

Genitourinary Cancers

The OncLive Genitourinary Cancer condition center page is a comprehensive resource for clinical news and expert insights across genitourinary (GU) malignancies, including renal cell carcinoma, urothelial carcinoma, and prostate cancer. This section features news articles, interviews in written and video format, and podcasts that focus on the evolving treatment paradigm of GU cancers and emerging research. 

Combination Approaches for Metastatic Renal Cell Carcinoma

OncLive Insights

Bevacizumab and Interferon in mRCC

Historical Perspectives on the Treatment of mRCC

Rationale for Combination Therapy in mRCC

Cabozantinib in mRCC

Nivolumab and Ipilimumab in mRCC

Antiangiogenic Resistance in mRCC

Making Decisions for Second-Line Therapy in mRCC

Second-Line Combination Therapy in mRCC

Lenvatinib and Everolimus in Relapsed/Refractory mRCC

Managing Patients on Lenvatinib/Everolimus in mRCC

Therapeutic Sequencing in mRCC

TKI/I-O Therapy in mRCC

Emerging TKI/I-O Options in mRCC

Novel Combination Therapies Under Investigation in mRCC

PD-L1 Testing in mRCC

Future Directions for Research in mRCC